Lattice Biologics' Revenue Finance Round

Lattice Biologics raised a round of funding on September 16, 2014. Investors include Grenville Strategic Royalty.

Lattice Biologics specializes in the field of cellular therapies and tissue engineering, with a focus on bone, skin, and cartilage regeneration. Lattice develops and processes biologic allograft produ…

Articles about Lattice Biologics' Revenue Finance Round: